vs
Public Storage（PSA）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Public Storage的季度营收约是Revvity的1.6倍（$1.2B vs $772.1M），Public Storage净利率更高（41.7% vs 12.7%，领先29.0%），Revvity同比增速更快（5.9% vs 3.3%），过去两年Revvity的营收复合增速更高（9.0% vs 2.5%）
Public Storage总部位于美国加利福尼亚州格伦代尔，是主营自助仓储业务的房地产投资信托，也是美国最大的自助仓储服务品牌，持有美国约9%的自助仓储面积。截至2024年12月31日，公司运营3073处自助仓储设施，总可出租净面积达2.21亿平方英尺。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
PSA vs RVTY — 直观对比
营收规模更大
PSA
是对方的1.6倍
$772.1M
营收增速更快
RVTY
高出2.6%
3.3%
净利率更高
PSA
高出29.0%
12.7%
两年增速更快
RVTY
近两年复合增速
2.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $772.1M |
| 净利润 | $507.1M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 40.7% | 14.5% |
| 净利率 | 41.7% | 12.7% |
| 营收同比 | 3.3% | 5.9% |
| 净利润同比 | -17.5% | 3.9% |
| 每股收益（稀释后） | $2.59 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PSARVTY
| Q4 25 | $1.2B | $772.1M | ||
| Q3 25 | $1.2B | $698.9M | ||
| Q2 25 | $1.2B | $720.3M | ||
| Q1 25 | $1.2B | $664.8M | ||
| Q4 24 | $1.2B | $729.4M | ||
| Q3 24 | $1.2B | $684.0M | ||
| Q2 24 | $1.2B | $691.7M | ||
| Q1 24 | $1.2B | $649.9M |
净利润PSARVTY
| Q4 25 | $507.1M | $98.4M | ||
| Q3 25 | $511.1M | $46.7M | ||
| Q2 25 | $358.4M | $53.9M | ||
| Q1 25 | $407.8M | $42.2M | ||
| Q4 24 | $614.6M | $94.6M | ||
| Q3 24 | $430.3M | $94.4M | ||
| Q2 24 | $518.1M | $55.4M | ||
| Q1 24 | $508.9M | $26.0M |
毛利率PSARVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率PSARVTY
| Q4 25 | 40.7% | 14.5% | ||
| Q3 25 | 42.3% | 11.7% | ||
| Q2 25 | 30.4% | 12.6% | ||
| Q1 25 | 34.8% | 10.9% | ||
| Q4 24 | 52.4% | 16.3% | ||
| Q3 24 | 36.7% | 14.3% | ||
| Q2 24 | 44.6% | 12.4% | ||
| Q1 24 | 44.3% | 6.8% |
净利率PSARVTY
| Q4 25 | 41.7% | 12.7% | ||
| Q3 25 | 41.8% | 6.7% | ||
| Q2 25 | 29.8% | 7.5% | ||
| Q1 25 | 34.5% | 6.4% | ||
| Q4 24 | 52.2% | 13.0% | ||
| Q3 24 | 36.2% | 13.8% | ||
| Q2 24 | 44.2% | 8.0% | ||
| Q1 24 | 44.0% | 4.0% |
每股收益（稀释后）PSARVTY
| Q4 25 | $2.59 | $0.86 | ||
| Q3 25 | $2.62 | $0.40 | ||
| Q2 25 | $1.76 | $0.46 | ||
| Q1 25 | $2.04 | $0.35 | ||
| Q4 24 | $3.22 | $0.77 | ||
| Q3 24 | $2.16 | $0.77 | ||
| Q2 24 | $2.66 | $0.45 | ||
| Q1 24 | $2.60 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $318.1M | $919.9M |
| 总债务越低越好 | $10.3B | — |
| 股东权益账面价值 | $9.2B | $7.3B |
| 总资产 | $20.2B | $12.2B |
| 负债/权益比越低杠杆越低 | 1.11× | — |
8季度趋势，按日历期对齐
现金及短期投资PSARVTY
| Q4 25 | $318.1M | $919.9M | ||
| Q3 25 | $296.5M | $931.4M | ||
| Q2 25 | $1.1B | $991.8M | ||
| Q1 25 | $287.2M | $1.1B | ||
| Q4 24 | $447.4M | $1.2B | ||
| Q3 24 | $599.0M | $1.2B | ||
| Q2 24 | $542.3M | $2.0B | ||
| Q1 24 | $271.6M | $1.7B |
总债务PSARVTY
| Q4 25 | $10.3B | — | ||
| Q3 25 | $10.0B | — | ||
| Q2 25 | $10.4B | — | ||
| Q1 25 | $9.4B | — | ||
| Q4 24 | $9.4B | — | ||
| Q3 24 | $9.5B | — | ||
| Q2 24 | $9.4B | — | ||
| Q1 24 | $9.1B | — |
股东权益PSARVTY
| Q4 25 | $9.2B | $7.3B | ||
| Q3 25 | $9.3B | $7.4B | ||
| Q2 25 | $9.4B | $7.6B | ||
| Q1 25 | $9.6B | $7.6B | ||
| Q4 24 | $9.7B | $7.7B | ||
| Q3 24 | $9.6B | $7.9B | ||
| Q2 24 | $9.7B | $7.9B | ||
| Q1 24 | $9.9B | $7.8B |
总资产PSARVTY
| Q4 25 | $20.2B | $12.2B | ||
| Q3 25 | $20.1B | $12.1B | ||
| Q2 25 | $20.5B | $12.4B | ||
| Q1 25 | $19.6B | $12.4B | ||
| Q4 24 | $19.8B | $12.4B | ||
| Q3 24 | $19.8B | $12.8B | ||
| Q2 24 | $19.8B | $13.4B | ||
| Q1 24 | $19.6B | $13.4B |
负债/权益比PSARVTY
| Q4 25 | 1.11× | — | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 1.11× | — | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 0.96× | — | ||
| Q3 24 | 0.99× | — | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.91× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $733.6M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | 1.45× | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流PSARVTY
| Q4 25 | $733.6M | $182.0M | ||
| Q3 25 | $875.1M | $138.5M | ||
| Q2 25 | $872.7M | $134.3M | ||
| Q1 25 | $705.1M | $128.2M | ||
| Q4 24 | $768.6M | $174.2M | ||
| Q3 24 | $798.8M | $147.9M | ||
| Q2 24 | $895.3M | $158.6M | ||
| Q1 24 | $665.6M | $147.6M |
自由现金流PSARVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | — | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | — | $112.2M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | — | $129.7M |
自由现金流率PSARVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | — | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | — | 20.5% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | — | 20.0% |
资本支出强度PSARVTY
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.7% |
现金转化率PSARVTY
| Q4 25 | 1.45× | 1.85× | ||
| Q3 25 | 1.71× | 2.97× | ||
| Q2 25 | 2.43× | 2.49× | ||
| Q1 25 | 1.73× | 3.03× | ||
| Q4 24 | 1.25× | 1.84× | ||
| Q3 24 | 1.86× | 1.57× | ||
| Q2 24 | 1.73× | 2.87× | ||
| Q1 24 | 1.31× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PSA
| Self Storage Operations | $1.1B | 93% |
| Ancillary Operations | $86.9M | 7% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
